This article by Scott Gavura discusses the findings of a recent study which concluded that PSA screening for prostate cancer offers no survival benefits | via Science based Medicine
In this article, the author discusses the controversy surrounding PSA testing, and the findings of a new study, “Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality”
The study included over 400,000 British men aged 50-69. Men were randomized into an RN appointment, where they were offered information on a PSA test, and if they chose, the test. The other group didn’t invite men for testing. After a 10 year period, the study found that there were more prostate cancers detected from this one-time testing. However, this group was no less likely to die from prostate cancer.
Given there was no difference in mortality between the two groups Gavura asks the question as to whether to PSA screen or not?
Full article: Gavura, S | PSA Screening for Prostate Cancer | Science based Medicine
Link to the research: Martin, R. et al .| Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer MortalityThe CAP Randomized Clinical Trial | JAMA | 2018 Vol 319(9) p883–895
Related: Why a one-off PSA test for prostate cancer is doing men more harm than good | Cancer Research UK